Glucocorticoid receptor translational isoforms in asthma
Glucocorticoid receptor translational isoforms in asthma
批准号:
8477836
负责人:
NICK LU
金额:
$4.47万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2012-08-31
关键词:
Adrenal GlandsAdverse effectsAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntigensApoptosisAsthmaBiological ModelsBone MarrowCD4 Positive T LymphocytesCell LineCell modelCellsDataDendritic CellsDevelopmentDiseaseDrug Delivery SystemsDrug or chemical Tissue DistributionEukaryotic Initiation FactorsGene ExpressionGene Expression RegulationGlucocorticoid ReceptorGlucocorticoid-induced apoptosisGlucocorticoidsGoalsHelper-Inducer T-LymphocyteImmuneImmunityImmunosuppressive AgentsIndividualInflammationInflammatoryInflammatory ResponseInformaticsLigandsLipopolysaccharidesLungMediastinal lymph node groupMediatingMessenger RNAMetabolic syndromeModelingMusOdds RatioOsteoblastsOsteoporosisPatternPharmaceutical PreparationsPituitary GlandPlayProductionProtein IsoformsRegulationRegulatory T-LymphocyteResistanceRoleScanningSentinelStagingStimulusT-LymphocyteT-Lymphocyte SubsetsTestingToll-like receptorsTranslationsWorkabstractingairborne allergenbasecell typecytokinedesignimprovedkillingspathogenrespiratoryrisk benefit ratioselective expressionstable cell linetherapy developmenttranslation factoruptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract: Glucocorticoids are indispensable in the treatment of asthma and other inflammatory diseases
although side effects such as hypothalamo-pituitary-adrenal suppression, metabolic syndrome, and
osteoporosis limit their use. Our goal is to understand the mechanisms by which the glucocorticoid receptor
(GR) mediates cell-specific functions, as this information may be useful in the development of treatments for
asthma with improved efficacy/risk ratios. We have recently discovered that the GR has eight distinct
translational isoforms expressed variably in a wide range of cell types. These GR isoforms have profoundly
different effects on gene expression. We hypothesize that selective GR translational isoforms mediate
distinct sensitivities to glucocorticoid-induced apoptosis and regulate cell-specific inflammatory
responses in T cell and dendritic cell subsets that are crucial in asthma. We propose that inflammatory
stimuli selectively regulate GR isoforms via translational mechanisms. To test these hypotheses, we will
examine primary T cells and dendritic cells obtained from a murine asthma model, cell lines expressing
individual GR isoforms, and bone marrow-derived dendritic cells. Studies in Aim 1 will determine in a murine
asthma model the identity and function of GR translational isoforms in helper T cells that are sensitive and
regulatory T cells (Tregs) that are resistant to glucocorticoid-induced apoptosis. Our preliminary data indicate
that helper T cells express predominantly the proapoptotic GR-A isoform whereas Tregs have predominantly
the GR-D isoforms that are incapable of inducing apoptosis in osteoblast and T cell model systems. We will
determine the role of selective GR isoforms in T cell subset-specific functions and glucocorticoid sensitivities.
Studies in Aim 2 will determine the identity and function of GR translational isoforms in immature and mature
dendritic cells that also have distinct sensitivities to glucocorticoid-induced apoptosis. Our preliminary data
indicate that immature dendritic cells switch from the GR-D isoforms to expressing the GR-A isoform after
maturation. The role of GR isoforms in distinct glucocorticoid sensitivities of immature (insensitive) and mature
(sensitive) dendritic cells and in maturational-stage specific functions will be determined. Studies in Aim 3 will
determine the role of translation machinery in regulating the expression of selective GR isoforms. Our previous
studies indicate that the GR translational isoforms are produced from a single species of mRNA via ribosomal
leaky scanning and ribosomal shunting. Based on our preliminary results, we will focus on the role of
eukaryotic initiation factors in selective expression of GR isoforms. These studies will improve our
understanding of the cell-specific actions of GR translational isoforms in asthma. Selective GR
isoforms are anticipated to mediate cell-specific sensitivities to glucocorticoids and regulate cell-
specific functions. In addition, these studies may provide a basis for the development of anti-
inflammatory drugs targeting or altering the expression of selective GR isoforms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glucocorticoid induced G-CSF in lung inflammation
-
批准号:9336499
-
项目类别:
-
资助金额:$39.13万
-
财政年份:2016
-
负责人:NICK LU
-
依托单位:
Glucocorticoids and glucocorticoid receptor translational isoforms
-
批准号:8773073
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2014
-
负责人:NICK LU
-
依托单位:
Glucocorticoids and glucocorticoid receptor translational isoforms
-
批准号:8890110
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2014
-
负责人:NICK LU
-
依托单位:
Glucocorticoid receptor translational isoforms in asthma
-
批准号:8240049
-
项目类别:
-
资助金额:$37.37万
-
财政年份:2009
-
负责人:NICK LU
-
依托单位:
Glucocorticoid receptor translational isoforms in asthma
-
批准号:7838659
-
项目类别:
-
资助金额:$25.29万
-
财政年份:2009
-
负责人:NICK LU
-
依托单位:
Glucocorticoid receptor translational isoforms in asthma
-
批准号:7786958
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2009
-
负责人:NICK LU
-
依托单位:
Glucocorticoid receptor translational isoforms in asthma
-
批准号:7663499
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2009
-
负责人:NICK LU
-
依托单位:
Glucocorticoid receptor translational isoforms in asthma
-
批准号:8448648
-
项目类别:
-
资助金额:$35.58万
-
财政年份:2009
-
负责人:NICK LU
-
依托单位:
Glucocorticoid receptor translational isoforms in asthma
-
批准号:8051828
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2009
-
负责人:NICK LU
-
依托单位:
Environment and Obesity: preventing stress hormone-induced obesity with genistein
-
批准号:7090949
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2007
-
负责人:NICK LU
-
依托单位:
Environment and Obesity: preventing stress hormone-induced obesity with genistein
-
批准号:7625922
-
项目类别:
-
资助金额:$10.77万
-
财政年份:2007
-
负责人:NICK LU
-
依托单位:
Environment and Obesity: preventing stress hormone-induced obesity with genistein
-
批准号:7487546
-
项目类别:
-
资助金额:$10.79万
-
财政年份:2007
-
负责人:NICK LU
-
依托单位:
海外基金